TransEnterix files U.S. marketing application for Senhance instruments for micro-procedures; shares up 2% after hours

|By:, SA News Editor

TransEnterix (NYSEMKT:TRXC) is up 2% after hours on the heels of its announcement that it has filed a 510(k) submission with the FDA seeking clearance for additional Senhance System instruments, including 3 mm diameter, for use in microlaparoscopic surgeries.

Subscribe for full text news in your inbox